Kyntra Bio, Inc.KYNB
Price (close)
$7.00
Market cap
$28.3M
P/E
0.2x
Revenue (TTM)
$4.6M
Net income
$183.2M
Dividend yield
—
1-year total return
-42.8%
Net margin
3967.8%
Revenue growth
-37.1%
Debt / equity
—
What Kyntra Bio, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $176.3M | $235.3M | $140.7M | $46.8M | $29.6M | $6.4M |
| Net income | -$189.3M | -$290.0M | -$293.7M | -$284.2M | -$47.6M | $183.5M |
| Free cash flow | $77.6M | -$87.4M | -$149.7M | -$317.5M | -$138.3M | -$4.8M |
More on KYNB.
- Kyntra Bio, Inc. summary
- Kyntra Bio, Inc. financial statements
- Kyntra Bio, Inc. key metrics
- Kyntra Bio, Inc. health scores and style box
- Kyntra Bio, Inc. earnings
- Kyntra Bio, Inc. dividends
- Kyntra Bio, Inc. valuation
- Kyntra Bio, Inc. ownership and insiders
- Kyntra Bio, Inc. peers
Figures from Kyntra Bio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.